1 University of Texas Southwestern Medical Center and Texas Scottish Rite Hospital, Dallas, TX
2 Texas Scottish Rite Hospital, Dallas, TX
3 University of Texas Southwestern Medical Center, Dallas, TX
Background. X-linked hypophosphatemia is characterized clinically by rickets and growth retardation. Therapy of this disorder with phosphate and vitamin D often produces nephrocalcinosis. The long-term effects of nephrocalcinosis on renal function in patients with X-linked hypophosphatemia are unknown. The purpose of this study was to evaluate the prevalence of glomerular and tubular disorders in patients with X-linked hypophosphatemia who developed nephrocalcinosis.
Methods. The creatinine clearance and the prevalence of renal tubular acidosis were compared in 19 patients with X-linked hypophosphatemia and nephrocalcinosis with 15 patients with X-linked hypophosphatemia Without nephrocalcinosis.
Results. Sixteen of the 19 patients (84%) with n nephrocalcinosis had a hyperchloremic metabolic acidosis compared with one of the 13 patients without nephrocalcinosis (P < .01). The serum bicarbonate of patients with nephrocalcinosis was 20.0 ± 0.7 as compared to 24.5 ± 0.6 mmol/L in patients without nephrocalcinosis (P < .01). The urinary anion gap was positive in all patients with acidosis (+62.1 ± 13.3 mmol/L). The creatinine clearance was 125 ± 6 mL/min/1.73 m2 in patients with nephrocal nephrocalcinosis and 124 ± 7 mLmin/1.73 m2 in those without nephrocalcinosis.
Conclusion. Therapy of X-linked hypophosphatemia is often associated with nephrocalcinosis. Nephrocaldnosis is associated with renal tubular acidosis in patients with X-linked hypophosphatemia.
Submitted on December 6, 1994
This article has been cited by other articles:
![]() |
M. Baum, S. Loleh, N. Saini, M. Seikaly, V. Dwarakanath, and R. Quigley Correction of proximal tubule phosphate transport defect in Hyp mice in vivo and in vitro with indomethacin PNAS, September 16, 2003; 100(19): 11098 - 11103. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. Seikaly and M. Baum Thiazide Diuretics Arrest the Progression of Nephrocalcinosis in Children With X-Linked Hypophosphatemia Pediatrics, July 1, 2001; 108(1): e6 - 6. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. Seikaly, R. Brown, and M. Baum The Effect of Recombinant Human Growth Hormone in Children With X-Linked Hypophosphatemia Pediatrics, November 1, 1997; 100(5): 879 - 884. [Abstract] [Full Text] [PDF] |
||||